Cite
Supplementary Figures and Methods from Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma
MLA
Michael R. Green, et al. Supplementary Figures and Methods from Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma. Apr. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....849a13b68a5b6bdd264f3e7fa3284959&authtype=sso&custid=ns315887.
APA
Michael R. Green, Ari M. Melnick, Robert G. Roeder, David A. Scheinberg, Ahmet Dogan, Cassian Yee, Anas Younes, José Baselga, Giorgio Inghirami, Oliver Weigert, Sattva S. Neelapu, Loretta Nastoupil, Anja Mottok, Sreejoyee Ghosh, Elisa de Stanchina, Matthew Durant, Stefan Alig, Eneda Toska, Man Chun John Ma, … Patrizia Mondello. (2023). Supplementary Figures and Methods from Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma.
Chicago
Michael R. Green, Ari M. Melnick, Robert G. Roeder, David A. Scheinberg, Ahmet Dogan, Cassian Yee, Anas Younes, et al. 2023. “Supplementary Figures and Methods from Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma,” April. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....849a13b68a5b6bdd264f3e7fa3284959&authtype=sso&custid=ns315887.